Abeona Therapeutics Inc. (ABEO) vs Sagimet Biosciences Inc. (SGMT)
A side-by-side comparison of Abeona Therapeutics Inc. and Sagimet Biosciences Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ABEO
Abeona Therapeutics Inc.
$5.02HealthcareDelayed quote: Oct 6, 2026, 1:05 PM EDT
SGMT
Sagimet Biosciences Inc.
$8.82HealthcareDelayed quote: Oct 6, 2026, 1:00 PM EDT
Total return — ABEO vs SGMT
growth of $100 · dividends reinvested · last 3yABEO +31.7% (+9.6%/yr)SGMT -43.4% (-17.3%/yr)ABEO compounded faster over this window
ABEO SGMT
ABEO vs SGMT: by the numbers
- •SGMT is the larger company ($287M vs $286M market cap).
- •Both run net losses; SGMT's is the smaller (0.00% vs -246.42% net margin).
Metrics side by side
Valuation
| Metric | ABEO | SGMT |
|---|---|---|
| P/S ratio | 11.20 | N/A |
| P/B ratio | 2.23 | 1.12 |
Profitability
| Metric | ABEO | SGMT |
|---|---|---|
| Gross margin | 73.68% | 0.00% |
| Operating margin | -1536.91% | 0.00% |
| Net margin | -246.42% | 0.00% |
| ROE | -49.11% | -18.38% |
| ROIC | -49.76% | -20.40% |
Growth (annualized)
| Metric | ABEO | SGMT |
|---|---|---|
| Revenue CAGR (5Y) | -10.26% | N/A |
| Total return CAGR (5Y) | -26.46% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.